Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Accounts Payables (2021 - 2025)

Cardio Diagnostics Holdings' Accounts Payables history spans 5 years, with the latest figure at $150734.0 for Q3 2025.

  • For Q3 2025, Accounts Payables rose 101.49% year-over-year to $150734.0; the TTM value through Sep 2025 reached $150734.0, up 101.49%, while the annual FY2024 figure was $87661.0, 63.96% down from the prior year.
  • Accounts Payables for Q3 2025 was $150734.0 at Cardio Diagnostics Holdings, up from $48724.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.1 million in Q4 2022 and bottomed at $33885.0 in Q4 2021.
  • The 5-year median for Accounts Payables is $150734.0 (2025), against an average of $318451.5.
  • The largest annual shift saw Accounts Payables skyrocketed 3142.55% in 2022 before it plummeted 92.0% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $33885.0 in 2021, then skyrocketed by 3142.55% to $1.1 million in 2022, then crashed by 77.86% to $243213.0 in 2023, then tumbled by 63.96% to $87661.0 in 2024, then skyrocketed by 71.95% to $150734.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Accounts Payables are $150734.0 (Q3 2025), $48724.0 (Q2 2025), and $108181.0 (Q1 2025).